The global deep brain stimulation devices market size is expected to reach USD 2.10 billion by 2025

Tuesday, June 26, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 26, 2018 /PRNewswire/ -- Deep Brain Stimulation Devices Market Size, Share & Trends Analysis Report By

Application (Pain Management, Epilepsy, Essential Tremor, OCD, Depression, Dystonia, Parkinson's), By Region, And Segment Forecasts, 2018 - 2025 Read the full report: The global deep brain stimulation devices
market size is expected to reach USD 2.10 billion by 2025 progressing at a CAGR of over 11.9% during the forecast period. Growing prevalence of Parkinson's disease coupled with surging demand for cost-efficient surgical procedures, minimally invasive in nature, is providing a fillip to the market. As per the statistics published by the Parkinson Disease Foundation, in 2010, around 10.0 million people were found to be suffering from this disease and this number is anticipated to grow at an unprecedented rate in the coming years. A significant rise in the usage of deep brain stimulators by neurologists in the treatment of various neurological diseases is supplementing the growth of the market.These diseases include Parkinson's disease, obsessive-compulsive disorder, essential tremors, and dystonia. Pending product approvals from regulatory authorities such as the U.S. FDA for the adoption of DBS in the treatment regime of refractory epilepsy is also estimated to offer significant growth opportunities to the market in the coming years. Moreover, advent of technologically advanced concepts in DBS systems such as fractionation of electric current and selective current steering, which induces positive patient outcomes, is further projected to fuel market growth prospects. Further Key Findings from the Report Suggest: • Parkinson's disease accounted for the leading share in the market in 2016 owing to benefits offered by DBS such as improvised motor symptoms for longer time period, fewer side effects, and ability to track momentary fluctuations • Increasing number of drug-resistant cases in treatment of Parkinson's disease is also a major factor escalating the growth of the market • Obsessive-compulsive disorder held the second largest share in terms of revenue as a result of failure of serotonin reuptake inhibitors (SSRi) and positive patient outcomes associated with DBS • North America registered substantial revenue share in the market, owing to extensive research activities aimed at studying possible outcomes with DBS in newer applications • Asia Pacific is projected to observe exponential growth during the forecast period due to growing awareness pertaining to benefits associated with stimulation devices and improving healthcare infrastructure • Increasing adoption of strategies such as new product development and research collaborations is rendering the market a highly competitive arena • Other significant strategies implemented by companies include promotional campaigns to heighten awareness levels regarding their products among healthcare professionals as well as patients.Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store